“Ray Hammond delivered a great keynote. He is a superb speaker.” Google
“Ray gave us an incredible, upbeat glimpse into the future.” Mastercard
“Ray Hammond is one of the best public speakers we have ever seen.” GE Corporation, Europe
“A really stunning keynote speech.” Microsoft
“Ray’s speech was uplifting, inspiring and visionary.” Vodafone
“Ray stimulated and inspired our North American sales team at the end of a very long day.” Ericsson Networks
“As a speaker, Ray Hammond has Mojo!” National Property Council of Australia.
“Ray Hammond was fabulous. He bent our minds.” Intel Corporation
“Ray – thank you for your terrific contribution to our Business Leadership Forum.” McKinsey & Co
“Ray was awesome at our 4th Annual Seminar in Montego Bay.” Ministry of Tourism, Jamaica
“Ray was brilliant at our client conference in Cape Town.” Telkom SA

Latest Tweets

YouTube Subscribe

Downloadable PDFs

Glimpses Of The Future

Promising New Alzheimer’s Drug Fast-Tracked In China!

 In a surprise to many researchers around the world, Chinese authorities recently approved a novel drug claimed to improve cognitive function in patients with Alzheimer’s disease.

The drug, derived from a marine algae, is the first new Alzheimer’s drug to reach the market anywhere in the world in almost 20 years, and is suggested to reduce neuroinflammation by modulating a person’s gut microbiome (the microbiome again!).

 GV-971, or sodium oligomannate, is derived from a common form of seaweed called brown algae. For several years the compound has been under investigation in China as a treatment to slow, or even reverse, cognitive decline associated with mild to moderate cases of Alzheimer’s disease.

The latest announcement from China’s National Medical Products Administration (NMPA) has granted the drug “conditional approval”, meaning it is to be fast-tracked to market based on positive early Phase 3 trial results. The “conditional approval” requires ongoing studies to verify efficacy and safety, however, it can now move to open market sales in China within the next month or two.

Read full article